ELTX

Elicio Therapeutics, Inc.

13.93

+1.40+11.17%

After Hours: 14.21 +0.28 +2.01%16:38 06/04 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE12.95/12.53

TODAY RANGE12.85-14.97

VOL294.09K

MARKET CAP265.87M

52 WEEK RANGE6.90-14.97

AVG VOL (3M)134.50K

% TURNOVER1.54%

TURNOVER--

P/E (TTM)-5.7837

% RANGE16.65%

EPS(TTM)-2.4085

P/E(FORWARD)-7.1620

P/B-180.6744

BVPS-0.0771

DIVIDEND--

P/S46.08

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP186.06M

SHARES OUTSTANDING19.09M

NEXT EARNINGS08/05-08/10

FREE FLOAT13.36M

LOT SIZE1

EX-DATE06/02/2023

News

Press Releases

Financial Reports

Profile

TipRanks·3d ago
Elicio Therapeutics publishes data on AMP-DNA adjuvant technology
PUBT·3d ago
Elicio Therapeutics reports preclinical AMP-DNA adjuvant study in Science Advances showing durable T-cell responses
TipRanks·05/28 15:27
Largest borrow rate increases among liquid names
TipRanks·05/28 10:26
Burns Reiterates Buy on ELI‑002 Program, Maintains $17 Price Target Amid Encouraging Early Efficacy Signals
TipRanks·05/27 13:23
Largest borrow rate increases among liquid names
TipRanks·05/21 12:45
Largest borrow rate increases among liquid names
TipRanks·05/12 20:35
Boris Peaker Initiates Buy on Elicio Therapeutics, Citing Promising Phase 2b ELI-002 7P Data and Setting $18 Price Target
Seeking Alpha·05/11 20:58
Elicio Therapeutics GAAP EPS of -$0.65 misses by $0.18
Reuters·05/11 20:16
Elicio Therapeutics Q1 net loss widens, cash runway extends into Q4 2026
PUBT·05/11 20:07
Elicio Therapeutics Q1 FY26 net loss widens to $11.8 million; loss per share narrows to $0.65
PUBT·04/30 12:14
Elicio Therapeutics to present at Bank of America Healthcare Conference
TipRanks·04/29 13:30
Analysts Offer Insights on Healthcare Companies: Definium Therapeutics (DFTX), Design Therapeutics (DSGN) and Elicio Therapeutics (ELTX)
Seeking Alpha·04/29 09:51
Elicio Therapeutics: Hoping To Capitalize On Massive KRAS Hype, But Time Is Running Out
PUBT·04/16 12:09
Elicio Therapeutics grants 21,210 inducement stock options at $11.78 per share
Dow Jones·04/15 14:49
Elicio Therapeutics Price Target Announced at $20.00/Share by Ladenburg Thalmann

Same Industry

Name/Symbol

Change%

Price

ELTX

REGN

GRDX

BIONTECH

BNTX

+2.69%

95.95

United Therapeutics Corp.

UTHR

-0.94%

556.82

SIGA

Vertex Pharmaceuticals Inc

VRTX

-0.10%

447.54

Moderna

MRNA

-0.80%

47.19

Charles Riv Labs Intl Inc

CRL

-0.35%

180.71

MEDP

TLPH

ICON plc

ICLR

-0.53%

136.07

CBPO

IQV

MOLECULAR PARTNERS AG

MOLN

+4.92%

4.200

GILD

PRAH

ARCT

Incyte Corp

INCY

-0.78%

96.74

Aptevo Therapeutics Inc

APVO

-1.91%

5.14

BSTC

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.